Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platinum-based neoadjuvant chemotherapy in early TNBC
NCT01672671Phase 2Completed
- Sponsor
- Russian Academy of Sciences
- Start
- Aug 2011
- Primary completion
- Jun 2015
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in triple negative breast cancer (TNBC), sponsored by Russian Academy of Sciences. Started Aug 2011; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
triple negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01672671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01672671.